We have written before about the Supreme Court’s impossibility preemption decision, Merck Sharpe & Dohme Corp. v. Albrecht, 139 S. Ct. 1668 (2019) (Albrecht) (here, here, here, and.
Pembro + Chemo in Early TNBC: From the Trial to the Clinic medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
Chinook Therapeutics Announces Update on Non-Renal Legacy Programs from Aduro Biotech Merger
Van Herk Investments to Form and Invest in Sairopa, a New Company Focused on Research and Development of B-Select Monoclonal Antibody Platform Programs
VANCOUVER, British Columbia and SEATTLE, April 05, 2021 (GLOBE NEWSWIRE) Chinook Therapeutics, Inc. (NASDAQ: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today announced a transaction with Van Herk Investments, a leading European life science investor, to create and fund a new company called Sairopa, with a pipeline focused on research and development of non-renal monoclonal antibodies generated through Aduro Biotech’s B-Select platform. Chinook will own approximately 40 percent of Sairopa after the first tranche of financing from Van Herk and have one seat on Sairopa’s Board of Directors.
Nicholas Pritzker,
Riaz Valani: Complaint Against Adam Bowen, Altria Client Services Llc, Altria Enterprises Llc, Altria Group Distribution Company, Altria Group, Inc., Hoyoung Huh, James Monsees, Juul Labs, Inc. F/k/A Pax Labs, Inc., Nicholas Pritzker, Philip Morris Usa, Inc., Riaz Valani ( Filing Fee $ 402 Receipt Number 0313-14791885.), Filed By Oxford Area School District. (attachments: # 1 Civil Cover Sheet, # 2 Designation Form, # 3 Appendix)(finken, Tracy) Demand For Trial By Jury By Oxford Area School District. (jl )
Case number 2:20-cv-06361 was filed in the U.S. District Court for the Eastern District of Pennsylvania.
Weekly Newsletter
Sign up ×
By signing up you agree to receive email newsletters or alerts from Pennsylvania Record. You can unsubscribe at any time. Protected by Google ReCAPTCHA.